Here's the latest variant picture for New Zealand.

DeFLuQE variants continue to dominate, with XEC.* struggling to break above 40%.

This quite an unusual picture as XEC.* is already dominant in most places.

The LP.8.1.* variant has mostly been below 10%.

#COVID19 #NZ #DeFLuQE #XEC #LP_8_1
🧵

Here's the latest variant picture with a global scope.

The DeFLuQE variants remain dominant, but they now appear to be in decline.

Growth of XEC.* has continued, reaching 37% recently.

#COVID19 #Global #DeFLuQE #XEC
🧵

Here's the latest variant picture for the United States.

DeFLuQE variants are still dominant, but growth has ended.

XEC.* growth might have stalled at around 20%, but recent sample sizes are thin.

#COVID19 #USA #DeFLuQE #FLiRT #XEC
🧵

Here's the latest variant picture for the United Kingdom.

DeFLuQE variants continue to dominate, but they are now in decline.

XEC.* grew to around 40%.

#COVID19 #UK #DeFLuQE #KP_3_1_1 #XEC
🧵

Here's the latest variant picture for Japan.

DeFLuQE variants have been rising to take over dominance from FLuQUE variants.

XEC.* grew to around 14%, but might have stalled there.

The recent rise in FLiRT variants is led by the LP.8.1 variant.

#COVID19 #Japan #DeFLuQE #FLiRT #FLuQE #XEC
🧵

Here's the latest variant picture with a global scope.

The DeFLuQE variants remain dominant, but growth appears to have stalled.

Growth of XEC.* has continued, reaching 28%.

#COVID19 #Global #DeFLuQE #XEC
🧵